{"id":"https://openalex.org/W7203870143","doi":"https://doi.org/10.17615/tkeg-zk87","title":"Nanoray-312: phase III study of NBTXR3 + radiotherapy \u00b1 cetuximab in elderly, platinum-ineligible locally advanced HNSCC","display_name":"Nanoray-312: phase III study of NBTXR3 + radiotherapy \u00b1 cetuximab in elderly, platinum-ineligible locally advanced HNSCC","publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W7203870143","doi":"https://doi.org/10.17615/tkeg-zk87"},"language":"en","primary_location":{"id":"doi:10.17615/tkeg-zk87","doi":"https://doi.org/10.17615/tkeg-zk87","is_oa":true,"landing_page_url":"https://doi.org/10.17615/tkeg-zk87","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.17615/tkeg-zk87","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082685694","display_name":"Sue Sun Yom","orcid":"https://orcid.org/0000-0002-0779-7476","observed_orcids":["https://orcid.org/0000-0002-0779-7476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yom, Sue S.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133891001","display_name":"Amanda Psyrri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Psyrri, Amanda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012247596","display_name":"Kiran Devisetty","orcid":"https://orcid.org/0000-0001-9762-6621","observed_orcids":["https://orcid.org/0000-0001-9762-6621"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Devisetty, Kiran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031303187","display_name":"Omar I. Vivar","orcid":"https://orcid.org/0009-0000-1461-3690","observed_orcids":["https://orcid.org/0009-0000-1461-3690"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivar, Omar I.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147679053","display_name":"Feng Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liu, Feng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021188790","display_name":"X. Liem","orcid":"https://orcid.org/0000-0002-9448-3757","observed_orcids":["https://orcid.org/0000-0002-9448-3757"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liem, Xavier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017670813","display_name":"Caroline Hoffmann","orcid":"https://orcid.org/0000-0002-4430-3439","observed_orcids":["https://orcid.org/0000-0002-4430-3439"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hoffmann, Caroline","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040628601","display_name":"Ana\u00efs Debard","orcid":"https://orcid.org/0000-0002-5423-6217","observed_orcids":["https://orcid.org/0000-0002-5423-6217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debard, Ana\u00efs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063649167","display_name":"Christophe Le Tourneau","orcid":"https://orcid.org/0000-0001-9772-4686","observed_orcids":["https://orcid.org/0000-0001-9772-4686"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Le Tourneau, Christophe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147741716","display_name":"Jinming Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu, Jinming","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059487992","display_name":"Sandra Nuyts","orcid":"https://orcid.org/0000-0002-5540-4796","observed_orcids":["https://orcid.org/0000-0002-5540-4796"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nuyts, Sandra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011222163","display_name":"S. Thureau","orcid":"https://orcid.org/0000-0001-5772-2336","observed_orcids":["https://orcid.org/0000-0001-5772-2336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thureau, S\u00e9bastien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063133514","display_name":"Eter Natelauri","orcid":"https://orcid.org/0000-0002-7675-009X","observed_orcids":["https://orcid.org/0000-0002-7675-009X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natelauri, Eteri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037837148","display_name":"Laetitia Finzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Finzi, Laetitia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030654014","display_name":"Martin Burian","orcid":"https://orcid.org/0000-0002-4099-9037","observed_orcids":["https://orcid.org/0000-0002-4099-9037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Burian, Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065893819","display_name":"Leonard A. Farber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farber, Leonard A.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026084126","display_name":"France Nguyen","orcid":"https://orcid.org/0000-0003-0717-7151","observed_orcids":["https://orcid.org/0000-0003-0717-7151"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nguyen, France","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079585578","display_name":"Trevor Hackman","orcid":"https://orcid.org/0000-0001-9330-2398","observed_orcids":["https://orcid.org/0000-0001-9330-2398"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hackman, Trevor G.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147668839","display_name":"Maria Lesnik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lesnik, Maria","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5147778407","display_name":"Zolt\u00e1n Tak\u00e1csi-Nagy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tak\u00e1csi-Nagy, Zolt\u00e1n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nbtxr3","display_name":"NBTXR3","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hafnium-oxide-nanoparticles","display_name":"hafnium oxide nanoparticles","score":0.949999988079071},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.8980000019073486},{"id":"https://openalex.org/keywords/locally-advanced-hnscc","display_name":"locally advanced HNSCC","score":0.9300000071525574},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7799999713897705},{"id":"https://openalex.org/keywords/platinum-ineligible-patients","display_name":"platinum-ineligible patients","score":0.8930000066757202},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.7540000081062317},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8899999856948853},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9350000023841858}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9218000173568726},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8507999777793884},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7152000069618225},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6901999711990356},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6534000039100647},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6316999793052673},{"id":"https://openalex.org/C2778424827","wikidata":"https://www.wikidata.org/wiki/Q5090613","display_name":"Chemoradiotherapy","level":3,"score":0.5236999988555908},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.5023000240325928},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.47429999709129333},{"id":"https://openalex.org/C3018411727","wikidata":"https://www.wikidata.org/wiki/Q3867488","display_name":"Head and neck","level":2,"score":0.42489999532699585},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4052000045776367},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3833000063896179},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.3750999867916107},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35690000653266907},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.3296999931335449},{"id":"https://openalex.org/C2993769353","wikidata":"https://www.wikidata.org/wiki/Q7598360","display_name":"Standard of care","level":2,"score":0.3271999955177307},{"id":"https://openalex.org/C155806632","wikidata":"https://www.wikidata.org/wiki/Q5299253","display_name":"Dose fractionation","level":3,"score":0.2728999853134155},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.27140000462532043},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.2687999904155731},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.25060001015663147}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.17615/tkeg-zk87","doi":"https://doi.org/10.17615/tkeg-zk87","is_oa":true,"landing_page_url":"https://doi.org/10.17615/tkeg-zk87","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.17615/tkeg-zk87","doi":"https://doi.org/10.17615/tkeg-zk87","is_oa":true,"landing_page_url":"https://doi.org/10.17615/tkeg-zk87","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306890","display_name":"American Society for Radiation Oncology","ror":"https://ror.org/054kfq324"},{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4307148372","https://openalex.org/W4286297610","https://openalex.org/W3093946930","https://openalex.org/W4392797783","https://openalex.org/W4387208120","https://openalex.org/W4405134557","https://openalex.org/W3208803581","https://openalex.org/W2898399762","https://openalex.org/W3030905219","https://openalex.org/W3172621952"],"abstract_inverted_index":{"Elderly":[0],"patients":[1],"with":[2,23,103,112],"locally":[3],"advanced":[4],"head":[5],"and":[6,35],"neck":[7],"squamous":[8],"cell":[9],"carcinoma":[10],"(LA-HNSCC)":[11],"are":[12,27,44],"often":[13],"excluded":[14],"from":[15],"clinical":[16],"trials.":[17],"However,":[18],"in":[19,96],"an":[20,37],"aging":[21],"population":[22],"competing":[24],"comorbidities,":[25],"many":[26],"ineligible":[28],"for":[29,40],"standard":[30],"of":[31,53,61,71],"care":[32],"cisplatin-based":[33],"chemoradiotherapy":[34],"represent":[36],"unmet":[38],"need":[39],"which":[41],"effective":[42],"treatments":[43],"urgently":[45],"needed.":[46],"NBTXR3,":[47],"a":[48,73,113],"first-in-class":[49],"intratumoral":[50],"radioenhancer":[51],"made":[52],"hafnium":[54],"oxide":[55],"nanoparticles,":[56],"enhances":[57],"the":[58,68],"tumor-killing":[59],"effect":[60],"radiotherapy.":[62],"In":[63],"this":[64],"paper,":[65],"we":[66],"describe":[67],"study":[69,81],"design":[70],"NANORAY-312,":[72],"global,":[74],"open-label,":[75],"randomized":[76],"(1:1)":[77],"phase":[78],"III":[79],"pivotal":[80],"comparing":[82],"NBTXR3":[83],"+":[84],"radiotherapy":[85,91],"\u00b1":[86,92],"cetuximab":[87,93],"(Investigator\u2019s":[88,94],"choice)":[89,95],"versus":[90],"500":[97],"eligible":[98],"patients,":[99],"aged":[100],"\u226560":[101],"years,":[102],"platinum-ineligible":[104],"LA-HNSCC.":[105],"The":[106],"primary":[107],"endpoint":[108,116],"is":[109],"progression-free":[110],"survival,":[111],"key":[114],"secondary":[115],"being":[117],"overall":[118],"survival.":[119]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-08-22T00:00:00"}